(Q80032013)

English

Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro

scientific article published on 01 April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

ChEBI release 2020-05-28

author name string

Yuichiro Mizuochi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kenji Okajima

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Naoaki Harada

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Perenlei Molor-Erdene

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Mitsuhiro Uchiba

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Hidefumi Komura

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Takako Tsuda

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Hirotada Katsuya

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 April 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Translational Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

149

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

223-230

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Neurohumoral control mechanisms in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Basic mechanisms in heart failure: the cytokine hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

The role of tumor necrosis factor in the pathophysiology of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Ventricular dysfunction and the risk of stroke after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Mode of death in chronic heart failure. A request and proposition for more accurate classification

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

LPS induction of gene expression in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Carvedilol for heart failure, with care

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Carvedilol differentially regulates cytokine production from activated human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Lipopolysaccharide stimulation of ERK1/2 increases TNF-alpha production via Egr-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Tumor necrosis factor in myocardial hypertrophy and ischaemia--an anti-apoptotic perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Statins in the treatment of chronic heart failure: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Role of tissue factor in hemostasis, thrombosis, and vascular development

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.11.008

7 January 2021

Identifiers

10.1016/J.TRSL.2006.11.008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17383596%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80032013&oldid=1756009584"